TKI Plus Checkpoint Inhibitor Without Chemotherapy Shows Promise as Initial Option in Advanced NSCLC

Co-mutations in DNA Damage-Response Pathways May Predict Effectiveness of Checkpoint Inhibitors in NSCLC

Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors

Deeper Dive: A Plethora of Prediction Models

Study Provides Insights That May Inform Prevention, Management of Mesothelioma

IASLC Releases Position Statement on Air Pollution on Earth Day

IASLC Responds to Call for Evidence

Researcher Reveals How Air Pollution May Cause Lung Cancer

The Evolution of Palliative Care for Metastatic Lung Cancer

Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture

Veterans Health Administration’s Lung Precision Oncology Program Helps Individualize Treatment

Management of Breathlessness in Lung Cancer Post-Surgery: An Interview With U.S. and U.K. Nurses